Evaluation model of the effect of Rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of ostheoarthritis. Reumatismo [Internet]. 2002 Dec. 30 [cited 2025 Jul. 1];54(4):331-9. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2002.331